Protagonist Therapeutics Inc (PTGX)
Fixed asset turnover
Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 315,090 | 60,137 | 123 | 123 | 982 | 26,704 | 35,221 | 45,507 | 46,913 | 27,380 | 24,330 | 27,139 | 31,091 | 28,549 | 25,678 | 12,604 | 6,408 | 4,321 | 3,955 | 10,051 |
Property, plant and equipment | US$ in thousands | 1,111 | 1,195 | 1,421 | 1,263 | 1,341 | 1,565 | 1,783 | 1,962 | 2,064 | 1,798 | 1,723 | 1,718 | 1,432 | 1,462 | 1,459 | 1,553 | 1,603 | 1,681 | 1,734 | 1,692 |
Fixed asset turnover | 283.61 | 50.32 | 0.09 | 0.10 | 0.73 | 17.06 | 19.75 | 23.19 | 22.73 | 15.23 | 14.12 | 15.80 | 21.71 | 19.53 | 17.60 | 8.12 | 4.00 | 2.57 | 2.28 | 5.94 |
March 31, 2024 calculation
Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $315,090K ÷ $1,111K
= 283.61
The fixed asset turnover ratio measures how efficiently a company is utilizing its fixed assets to generate revenue. A higher fixed asset turnover generally indicates better efficiency in generating sales from its investments in fixed assets.
Upon analyzing the fixed asset turnover of Protagonist Therapeutics Inc over the past several quarters, we observe significant fluctuations in the ratio. For the most recent period ending March 31, 2024, the fixed asset turnover ratio stood at an impressive 283.61, indicating a substantial increase in efficiency in utilizing fixed assets to drive sales.
However, looking at historical data, we can see that the fixed asset turnover ratio has been quite volatile, with values ranging from as low as 0.09 to as high as 283.61. This variability suggests fluctuations in the company's ability to efficiently utilize its fixed assets to generate revenue over time.
It is essential for Protagonist Therapeutics Inc to closely monitor and manage its fixed asset turnover ratio to ensure consistent and optimal utilization of its fixed assets in generating sales. Further analysis and comparison with industry benchmarks may provide additional insights into the company's operational efficiency and potential areas for improvement.
Peer comparison
Mar 31, 2024